In addition to AFP, emerging biomarkers such as des-gamma-carboxy prothrombin (DCP) and lectin-bound AFP (AFP-L3) are being investigated for their potential to improve diagnostic accuracy in HCC screening [3,22]. Here, AFP is linked to hepatocellular carcinoma.